Last $2.30 USD
Change Today -0.06 / -2.54%
Volume 1.3M
GALE On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gabriel N. Hortobagyi M.D., F.A.C.P.

Member of Scientific Advisory Board, Galena Biopharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 34 board members in 4 different organizations across 4 different industries.

See Board Relationships
----

Background*

Dr. Gabriel N. Hortobagyi, M.D., F.A.C.P. is a Professor of Medicine, Chairman of the Department of Breast Medical Oncology and Nellie B. Connally Chair in Breast Cancer at the University of Texas M.D. Anderson Cancer Center (MDACC). Dr. Hortobagyi joined MDACC as a Medical Oncology Fellow in 1974 As a member of the M.D. Anderson faculty since 1976, he has been instrumental in developing combination chemotherapy for previously inoperable breast tumors and for improving ...

Read Full Background

Corporate Headquarters*

4640 SW Macadam Avenue
Portland, Oregon 97239

United States

Phone: 855-855-4253
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education 1970
Universidad Nacional de Colombia
Unknown/Other Education
Case Western Reserve University Hospital

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALE:US $2.30 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Mortazavi Chief Executive and Director
Silence Therapeutics plc
70.0K GBP
Peter French B.Sc, M.Sc, Ph.D., MBAChief Executive Officer, Managing Director and Director
Benitec Biopharma Limited
A$450.0K
Hans G. C. P. Schikan Chief Executive Officer and Member of Management Board
Prosensa Holding N.V.
--
Mark J. Murray Ph.D.Chief Executive Officer, President and Director
Tekmira Pharmaceuticals Corporation
$377.5K
Kleanthis G. Xanthopoulos Ph.D.Chief Executive Officer, President, Principal Financial & Accounting Officer and Director
Regulus Therapeutics Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALENA BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.